Drug Utilization Study for Pirinase Hayfever Relief
Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
The purpose is to obtain real-world information on how consumers are complying with the
product labelling This study will coincide with the launch of Pirinase Hayfever Relief for
Adults 0.05% Nasal Spray in the United Kingdom (UK).